Alcohol is involved in over 20% of opioid-related overdose deaths, and co-occurring alcohol use disorder (AUD) significantly increases the risk of all-cause mortality among opioid use disorder (OUD) patients. Co-morbid opioid and alcohol use can be a potentially dangerous combination that can damage a person’s brain and body. Additionally, treating co-morbid opioid and alcohol use can lead to greater treatment complications compared to the treatment of either substance on its own. This webinar will discuss the use of medications and other integrated care strategies to improve treatment for co-morbid opioid and alcohol use disorders. Presenter: Sarah Kawasaki, PhD, Director of Addictions Services, Pennsylvania Psychiatric Institute (PPI) Assistant Professor of Psychiatry and Internal Medicine at Penn State Hershey Medical Center.
